Mary Cushman/X
Oct 12, 2025, 11:28
Is it time for GLP1 receptor agonists in VTE care?
Mary Cushman, Hematologist, University Distinguished Professor and Vice Chair for Emerging Researchers at UVM Department of Medicine, posted on X:
”Is it time for GLP1 receptor agonists in VTE care?
– In people with BMI >30, GLP-1 RA associated w/ 27% lower risk of venous thrombosis compared to use of other obesity reducing meds.
– Data from EHRs of 140 institutions.
– Target trial design.”
Stay updated with Hemostasis Today.
-
Feb 12, 2026, 16:36Tagreed Alkaltham: Tranexamic Acid in PBM
-
Feb 12, 2026, 16:35Paul Lambis Announces Maria Hadjidemetriou as a Speaker at Cyprus Diaspora Forum
-
Feb 12, 2026, 16:34Rahul Bhargava: Breaking Myths About Bone Marrow Transplant
-
Feb 12, 2026, 16:29Arun V J: Can You Be A Doctor And Still Be Stupid?
-
Feb 12, 2026, 16:26Changing the Narrative Around PPH – End Postpartum Hemorrhage
-
Feb 12, 2026, 16:20Mahesan Subramaniam: The Protective Switch in Brain Immune Cells Could Slow Alzheimer’s Disease
-
Feb 12, 2026, 16:13Lale Tokgözoğlu: Top 10 Dyslipidemia Papers of 2025
-
Feb 12, 2026, 16:10Neelam Mohan: Breaking Down Anemia from Causes and Testing to Treatment and Prevention
-
Feb 12, 2026, 16:04Irma Bagdoniene: From Estimating Risk to Seeing Disease in Preventive Cardiology